SCHIZOAFFECITVE DISORDER
Clinical trials for SCHIZOAFFECITVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECITVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECITVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
VR mindfulness may tame aggression in schizophrenia
Symptom relief Recruiting nowThis study tests whether a virtual reality mindfulness app can help people with schizophrenia or schizoaffective disorder control impulsive aggression. About 58 participants will use the VR app or do distraction tasks, and have their brain activity measured with fMRI. The goal is…
Matched conditions: SCHIZOAFFECITVE DISORDER
Phase: NA • Sponsor: Manhattan Psychiatric Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Brain scans reveal how new schizophrenia drug cobenfy works
Knowledge-focused Recruiting nowThis study will use brain scans (PET/MRI) to see how the drug Cobenfy affects dopamine in the brains of 12 people with schizophrenia. Participants will take one of three doses of Cobenfy for 5 weeks and get a brain scan before and after treatment. The goal is to understand how th…
Matched conditions: SCHIZOAFFECITVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC